Vanguard Global Advisers’s ADARx Pharmaceuticals ADRX Stock Holding History
Bought
Maintained
Sold
Other funds holding ADRX
SL
Vanguard Global Advisers's ADRX Position: Q3 2026 in Review
Vanguard Global Advisers opened a new position in ADARx Pharmaceuticals (ADRX) in Q3 2026: 366 shares worth $7.3K. The stake represents ﹤0.01% of the portfolio and ranks #3550 among its holdings.
62 funds tracked by Wall St. Rank hold ADRX as of Q3 2026.
- Vanguard Global Advisers held 366 shares of ADARx Pharmaceuticals worth $7.3K as of Q3 2026.
- ADARx Pharmaceuticals was a new Vanguard Global Advisers position in Q3 2026.
- ADARx Pharmaceuticals made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3550 holding.
- 62 funds tracked by Wall St. Rank held ADARx Pharmaceuticals as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.